APGE
Apogee Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -30.0% ·
share flow +20.0% ·
net new positions -20.0%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +12 | 31.80M | $4.18B | +21 | −9 |
| Q1 2026 | 96 | +7 | 41.18M | $3.45B | +13 | −6 |
| Q4 2025 | 88 | 0 | 38.24M | $2.89B | — | — |
| Q3 2025 | 17 | -2 | 25.40M | $1.01B | — | −2 |
| Q2 2025 | 16 | +1 | 22.08M | $959.13M | +1 | — |
| Q1 2025 | 12 | -1 | 10.37M | $387.41M | — | −1 |
| Q4 2024 | 13 | +4 | 9.16M | $415.03M | +4 | — |
| Q3 2024 | 8 | -5 | 7.45M | $437.40M | — | −5 |
| Q2 2024 | 13 | — | 6.20M | $244.16M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.81M | +35.7% | $282.80M | 0.1% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | Geode Capital Management ✦ (passive) | 823.84K | +11.2% | $48.40M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | T. Rowe Price ✦ | 758.08K | -1.3% | $44.53M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | Point72 Asset Management ✦ | 707.27K | +162.7% | $41.54M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 199.31K | -34.0% | $11.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Millennium Management ✦ | 90.01K | -7.3% | $5.29M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 49.66K | -4.5% | $2.92M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 3.67K | -95.5% | $215,869 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Renaissance Technologies | $6.15M | was 0.0% |
| Citadel Advisors | $4.58M | was 0.0% |
| Adage Capital Partners | $1.97M | was 0.0% |
| Norges Bank | $476,961 | was 0.0% |
| AQR Capital Management | $453,902 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 224 holders, 77.95M shares, $5.58B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
9.8% of class · View original SEC filing ↗